116 related articles for article (PubMed ID: 1301238)
1. Serotonin (5-HT2) receptor mediated enhancement of cortical unit activity.
Neuman RS; Zebrowska G
Can J Physiol Pharmacol; 1992 Dec; 70(12):1604-9. PubMed ID: 1301238
[TBL] [Abstract][Full Text] [Related]
2. 5-HT1C receptors in the serotonergic control of periaqueductal gray induced aversion in rats.
Jenck F; Broekkamp CL; Van Delft AM
Psychopharmacology (Berl); 1990; 100(3):372-6. PubMed ID: 2107558
[TBL] [Abstract][Full Text] [Related]
3. Involvement of the 5-HT2 receptor in the 5-HT receptor-mediated stimulation of prolactin release.
Albinsson A; Palazidou E; Stephenson J; Andersson G
Eur J Pharmacol; 1994 Jan; 251(2-3):157-61. PubMed ID: 8149973
[TBL] [Abstract][Full Text] [Related]
4. Habituation of tactile startle is altered by drugs acting on serotonin-2 receptors.
Geyer MA; Tapson GS
Neuropsychopharmacology; 1988 May; 1(2):135-47. PubMed ID: 3150805
[TBL] [Abstract][Full Text] [Related]
5. A pronociceptive role for the 5-HT2 receptor on spinal nociceptive transmission: an in vivo electrophysiological study in the rat.
Rahman W; Bannister K; Bee LA; Dickenson AH
Brain Res; 2011 Mar; 1382():29-36. PubMed ID: 21276431
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of 5-HT1A and 5-HT2/5-HT1C receptors induce oxytocin release in the male rat.
Bagdy G; Kalogeras KT
Brain Res; 1993 May; 611(2):330-2. PubMed ID: 8334526
[TBL] [Abstract][Full Text] [Related]
7. Effects of the 5-HT1C/5-5-HT2 receptor agonists DOI and alpha-methyl-5-HT on plasma glucose and insulin levels in the rat.
Chaouloff F; Laude D; Baudrie V
Eur J Pharmacol; 1990 Oct; 187(3):435-43. PubMed ID: 2127400
[TBL] [Abstract][Full Text] [Related]
8. Modulation of rat neocortical high-voltage spindle activity by 5-HT1/5-HT2 receptor subtype specific drugs.
Jäkälä P; Sirviö J; Koivisto E; Björklund M; Kaukua J; Riekkinen P
Eur J Pharmacol; 1995 Aug; 282(1-3):39-55. PubMed ID: 7498288
[TBL] [Abstract][Full Text] [Related]
9. Activation of 5-HT2 receptors facilitates depolarization of neocortical neurons by N-methyl-D-aspartate.
Rahman S; Neuman RS
Eur J Pharmacol; 1993 Feb; 231(3):347-54. PubMed ID: 8449227
[TBL] [Abstract][Full Text] [Related]
10. Excitatory responses to serotonin (5-HT) in neurons of the rat piriform cortex: evidence for mediation by 5-HT1C receptors in pyramidal cells and 5-HT2 receptors in interneurons.
Sheldon PW; Aghajanian GK
Synapse; 1991 Nov; 9(3):208-18. PubMed ID: 1776132
[TBL] [Abstract][Full Text] [Related]
11. Effects of imipramine and serotonin-2 agonists and antagonists on serotonin-2 and beta-adrenergic receptors following noradrenergic or serotonergic denervation.
Eison AS; Eison MS; Yocca FD; Gianutsos G
Life Sci; 1989; 44(19):1419-27. PubMed ID: 2785627
[TBL] [Abstract][Full Text] [Related]
12. Evidence that 5-HT2 receptor activation decreases noradrenaline release in rat hippocampus in vivo.
Done CJ; Sharp T
Br J Pharmacol; 1992 Sep; 107(1):240-5. PubMed ID: 1422575
[TBL] [Abstract][Full Text] [Related]
13. Competitive antagonism by recognized 5-HT2 receptor antagonists at 5-HT1C receptors in pig choroid plexus.
Sahin-Erdemli I; Schoeffter P; Hoyer D
Naunyn Schmiedebergs Arch Pharmacol; 1991 Aug; 344(2):137-42. PubMed ID: 1944609
[TBL] [Abstract][Full Text] [Related]
14. Serotonin modifies the spontaneous spiking activity of gracile nucleus neurons in rats: role of 5-HT1A and 5-HT2 receptors.
Grasso C; Li Volsi G; Barresi M
Arch Ital Biol; 2016 Jun; 154(2-3):39-49. PubMed ID: 27918061
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
Kleven MS; Assié MB; Koek W
J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of 5-HT2 receptors in the rat brain by repeated administration of SR 46349B, a selective 5-HT2 receptor antagonist.
Rinaldi-Carmona M; Bouaboula M; Congy C; Oury-Donat F; Simiand J; Shire D; Casellas P; Soubrié P; Brelière JC; Le Fur G
Eur J Pharmacol; 1993 Jun; 246(1):73-80. PubMed ID: 8354344
[TBL] [Abstract][Full Text] [Related]
17. Action of serotonin in the medial prefrontal cortex: mediation by serotonin3-like receptors.
Ashby CR; Edwards E; Wang RY
Synapse; 1992 Jan; 10(1):7-15. PubMed ID: 1536032
[TBL] [Abstract][Full Text] [Related]
18. Vascular and cardiac effects of alpha-methyl-5-HT and DOI are mediated by different 5-HT receptors in the pithed rat.
Chaouche-Teyara K; Fournier B; Safar M; Dabiré H
Eur J Pharmacol; 1993 Nov; 250(1):67-75. PubMed ID: 7907025
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterization of serotonin receptor subtypes involved in vasopressin and plasma renin activity responses to serotonin agonists.
Bagdy G; Sved AF; Murphy DL; Szemeredi K
Eur J Pharmacol; 1992 Jan; 210(3):285-9. PubMed ID: 1535317
[TBL] [Abstract][Full Text] [Related]
20. Effects of various serotonin receptor subtype-selective antagonists alone and on m-chlorophenylpiperazine-induced neuroendocrine changes in rats.
Aulakh CS; Hill JL; Murphy DL
J Pharmacol Exp Ther; 1992 Nov; 263(2):588-95. PubMed ID: 1432690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
